01 1Curia
01 1BETAMETHASONE SODIUM PHOSPHATE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-12-07
Pay. Date : 2023-09-27
DMF Number : 38831
Submission : 2023-09-20
Status : Active
Type : II
20
Curia Spain Sau, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is BETAMETHASONE SODIUM PHOSPHATE, with a corresponding US DMF Number 38831.
Remarkably, this DMF maintains an Active status since its submission on September 20, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 07, 2023, and payment made on September 27, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
